Your browser doesn't support javascript.
loading
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.
Salgia, Ravi; Stille, John R; Weaver, R Waide; McCleod, Michael; Hamid, Oday; Polzer, John; Roberson, Stephanie; Flynt, Amy; Spigel, David R.
Afiliação
  • Salgia R; Department of Medicine, The University of Chicago, Chicago, IL, United States. Electronic address: rsalgia@coh.org.
  • Stille JR; Eli Lilly and Company, Indianapolis, IN, United States.
  • Weaver RW; Florida Cancer Specialists, St. Petersburg, FL, United States.
  • McCleod M; Florida Cancer Specialists, Fort Myers, FL, United States.
  • Hamid O; Eli Lilly and Company, Indianapolis, IN, United States.
  • Polzer J; Eli Lilly and Company, Indianapolis, IN, United States.
  • Roberson S; Eli Lilly and Company, Indianapolis, IN, United States.
  • Flynt A; PharPoint Research Inc., Durham, NC, United States.
  • Spigel DR; Lung Cancer Research Program, Sarah Cannon Research Institute, LLC, Nashville, TN, United States.
Lung Cancer ; 105: 7-13, 2017 03.
Article em En | MEDLINE | ID: mdl-28236984
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article